Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease

被引:3
|
作者
Balin, Brian J. [1 ,2 ]
Little, C. Scott [2 ]
Hammond, Christine J. [2 ]
Appelt, Denah M. [2 ,3 ]
Whittum-Hudson, Judith A. [4 ]
Gerard, Herve C. [4 ]
Hudson, Alan P. [4 ]
机构
[1] Philadelphia Coll Osteopath Med, Dept Pathol Microbiol Immunol & Forens Med, Philadelphia, PA 19131 USA
[2] Philadelphia Coll Osteopath Med, Ctr Chron Disorders Aging, Philadelphia, PA 19131 USA
[3] Dept Neurosci Pharmacol & Physiol, Philadelphia, PA USA
[4] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA
关键词
Alzheimer's disease; antyloid; animal models antibiotic; APOE; Chlamydia pneumoniae; etiology; infection; LOAD; neuroinflammation;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sporadic, late-onset Alzheimer's disease (LOAD) is a non-familial, progressive neurodegenerative disease that is now the most common and severe form of dementia in the elderly. That dementia is a direct result of neuronal damage and loss associated with accumulations of abnormal protein deposits in the brain. Great strides have been made in the past 20 years with regard to understanding the pathological entities that arise in the AD brain, both for familial AD (similar to 5% of all cases) and LOAD (similar to 95% of all cases). The neuropathology observed includes: neuritic senile plaques (NSPs), neurofibrillary tangles (NFTs), neuropil threads (NPs), and often deposits of cerebrovascular amyloid. Genetic, biochemical, and immunological analyses have provided a relatively detailed knowledge of these entities, but our understanding of the "trigger" events leading to the many cascades resulting in this pathology and neurodegeneration is still quite limited. For this reason, the etiology of AD, in particular LOAD, has remained elusive. However, a number of recent and ongoing studies have implicated infection in the etiology and pathogenesis of LOAD. This review focuses specifically on infection with Chlamydophila (Chlamydia) pneumoniae in LOAD and how this infection may function as a "trigger or initiator" in the pathogenesis of this disease.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 50 条
  • [11] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [12] The 'eye test' in recognition of late-onset Alzheimer's disease
    Caputo, L
    Casartelli, M
    Perrone, C
    Santori, M
    Annoni, G
    Vergani, C
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1998, 27 (02) : 171 - 177
  • [13] α2-macroglobulin in late-onset Alzheimer's disease
    Kovacs, DM
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 473 - 479
  • [14] Genetics of late-onset Alzheimer's disease: progress and prospect
    Li, Yonghong
    Grupe, Andrew
    PHARMACOGENOMICS, 2007, 8 (12) : 1747 - 1755
  • [15] Type 2 Diabetes and Late-Onset Alzheimer's Disease
    Cheng, D.
    Noble, J.
    Tang, M. X.
    Schupf, N.
    Mayeux, R.
    Luchsinger, J. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (06) : 424 - 430
  • [16] Identification of novel genes in late-onset Alzheimer's disease
    Pericak-Vance, MA
    Grubber, J
    Bailey, LR
    Hedges, D
    West, S
    Santoro, L
    Kemmerer, B
    Hall, JL
    Saunders, AM
    Roses, AD
    Small, GW
    Scott, WK
    Conneally, PM
    Vance, JM
    Haines, JL
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (9-10) : 1343 - 1352
  • [17] Alzheimer's disease murine models: focus on late-onset disease
    Potenza, M. A.
    Nacci, C.
    Carratu, M. R.
    DRUGS OF THE FUTURE, 2020, 45 (02) : 109 - 117
  • [18] GAB2 is not associated with late-onset Alzheimer's disease in Japanese
    Miyashita, Akinori
    Arai, Hiroyuki
    Asada, Takashi
    Imagawa, Masaki
    Shoji, Mikio
    Higuchi, Susumu
    Urakami, Katsuya
    Toyabe, Shinichi
    Akazawa, Kohei
    Kanazawa, Ichiro
    Ihara, Yasuo
    Kuwano, Ryozo
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (05) : 682 - 686
  • [19] Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
    Spina, Salvatore
    La Joie, Renaud
    Petersen, Cathrine
    Nolan, Amber L.
    Cuevas, Deion
    Cosme, Celica
    Hepker, Mackenzie
    Hwang, Ji-Hye
    Miller, Zachary A.
    Huang, Eric J.
    Karydas, Anna M.
    Grant, Harli
    Boxer, Adam L.
    Gorno-Tempini, Maria Luisa
    Rosen, Howard J.
    Kramer, Joel H.
    Miller, Bruce L.
    Seeley, William W.
    Rabinovici, Gil D.
    Grinberg, Lea T.
    BRAIN, 2021, 144 : 2186 - 2198
  • [20] Assessment of the genetic variance of late-onset Alzheimer's disease
    Ridge, Perry G.
    Hoyt, Kaitlyn B.
    Boehme, Kevin
    Mukherjee, Shubhabrata
    Crane, Paul K.
    Haines, Jonathan L.
    Mayeux, Richard
    Farrer, Lindsay A.
    Pericak-Vance, Margaret A.
    Schellenberg, Gerard D.
    Kauwe, John S. K.
    NEUROBIOLOGY OF AGING, 2016, 41